Procter & Gamble Current Liabilities
The Current Liabilities of Procter & Gamble (PG) as of Oct 6, 2026 is 38.69 B USD. In the previous year, Current Liabilities was 56.89 B USD — a change of -31.98% (lower).
Get this data via API
Financial Data API
Current Liabilities
38.69 BUSD
YoY
-31.98%
Last updated:
The Procter & Gamble Current Liabilities history
3 Years
10 Years
25 Years
Max
| YEAR | Current Liabilities | YoY |
|---|---|---|
| 38.69 BUSD | -31.98% | |
| 56.89 BUSD | +22.90% | |
| 46.29 BUSD | -5.16% | |
| 48.81 BUSD | +7.15% | |
| 45.55 BUSD | -1.75% | |
| 46.36 BUSD | +4.15% | |
| 44.51 BUSD | +6.56% | |
| 41.77 BUSD | +10.67% | |
| 37.74 BUSD | -0.71% | |
| 38.01 BUSD | -5.41% | |
| 40.19 BUSD | +3.14% | |
| 38.96 BUSD | -14.57% | |
| 45.61 BUSD | +7.18% | |
| 42.55 BUSD | +26.19% | |
| 33.72 BUSD | -4.60% | |
| 35.35 BUSD | +17.73% | |
| 30.03 BUSD | -28.86% | |
| 42.20 BUSD | +13.30% | |
| 37.25 BUSD | -13.07% | |
| 42.85 BUSD | +36.01% | |
| 31.50 BUSD | -10.44% | |
| 35.18 BUSD | +12.19% | |
| 31.35 BUSD | +65.34% | |
| 18.96 BUSD | +1.67% | |
| 18.65 BUSD | +25.26% | |
| 14.89 BUSD | +43.28% | |
| 10.39 BUSD | -7.44% | |
| 11.23 BUSD | -16.69% | |
| 13.48 BUSD | +13.04% | |
| 11.92 BUSD | -2.48% | |
| 12.23 BUSD | -8.49% | |
| 13.36 BUSD | +7.96% | |
| 12.38 BUSD | -4.34% | |
| 12.94 BUSD | +10.02% | |
| 11.76 BUSD | +11.89% | |
| 10.51 BUSD | +31.30% | |
| 8.00 BUSD | +20.29% | |
| 6.65 BUSD | +6.60% | |
| 6.24 BUSD | +22.01% | |
| 5.12 BUSD | -0.99% | |
| 5.17 BUSD | +99.58% | |
| 2.59 BUSD | +9.06% | |
| 2.37 BUSD | +14.24% | |
| 2.08 BUSD | — |
Procter & Gamble Stock analysis
Frequently Asked Questions about Procter & Gamble stock
Current Liabilities of Procter & Gamble is 38.69 B USD in 2026.
Current Liabilities of Procter & Gamble changed from 56.89 B USD to 38.69 B USD, representing a -31.98% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Current Liabilities Procter & Gamble since 2006 – with annual values, charts, and detailed analysis.
Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.
Current Liabilities's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Procter & Gamble historically and in real time.
Balance Sheet — Procter & Gamble
All Key Metrics — Procter & Gamble
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth